Novo Pays PE Firm $708M For Stake In Chr. Hansen

Law360, New York (January 11, 2012, 3:26 PM EST) -- Novo A/S, the parent of diabetes care company Novo Nordisk A/S, is buying 35.4 million shares of Chr. Hansen Holding A/S for $708 million from private equity firm PAI Partners SAS, which is divesting its position at a profit, the companies said Wednesday.

Novo will pay 117 Danish kroner ($19.97) per share, and the purchase will boost its position in the Horsholm, Denmark-based Chr. Hansen — which makes ingredients for foods, pharmaceuticals and agricultural products — to more than 25 percent of the company.

"Chr. Hansen...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.